Vein Thrombosis Risk in Women and Travel by Tsikouras, Panagiotis et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Vein Thrombosis Risk in Women 
and Travel
Panagiotis Tsikouras, Xanthoula Anthoulaki, 
Theodora Deftereou, Anna Chalkidou, Anastasia Bothou, 
Fotini Gaitatzi, Eleftherios Chatzimichael, 
Selma Gyroglou, Arsou Chalil Bourazan, George Stanulov, 
Spyridon Michalopoulos, John Tsirkas, Irene Babageogaka, 
Werner Rath, Georg-Friedrich Von Tempelhoff, 
Stefanos Zervoudis, Georgios Iatrakis, Georgios Galazios  
and Nikolaos Nikolettos
Abstract
Deep vein thrombosis (DVT) of the lower limbs is a serious condition that can 
lead to pulmonary embolism (PE) in about 15–24% of cases. If it is not diagnosed/
treated timely, nearly 15% of these PE are lethal. The relationship between travel 
and staying in the same position for a long time is well-known since World War 
II. Generally, it is more frequent in air flights. It is also associated with the economic 
downturn in airplanes because passengers have limited space and have greater dif-
ficulty of moving. It is estimated that approximately 1–6% of long-haul passengers 
arrive at their destination with a clot in their veins, but most DVT are asymptomatic.
Keywords: thrombosis, travel risk factors
1. Introduction
The real incidence of deep vein thrombosis is not fully known, due to the fact 
that the studies were depended only on clinical data (the majority of the reported 
cases had no clinical signs) without confirmation by laboratory and ultrasound 
findings. A further reason is that the referred studies investigated either DVT or 
PE and rarely both of the diseases [1, 2]. D-dimers have prognostic value only in 
50% of cases of deep vein thrombosis or pulmonary embolism [3, 4]. Most of the 
published studies indicate that there is an increased risk of venous thrombosis 
when the travel duration is more than 4 h [3, 4]. Deep vein thrombosis is a serious 
health issue involving at least half a million Americans each year, and at least 1 in 
10 will die suddenly. It depends on the mode of travel either by air flight company 
or car, bus, and train based fully on all travel-related risks of thrombosis. It is 
estimated that the risk of such an episode occurring during a long travel is 3–5%, 
with no reliable international accurate data [5–8]. The reason for the increased risk 
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of venous thrombosis is an exclusive phenomenon of all travel-related thromboses, 
which play a role in clot formation. Stasis during the journey, the pressure of the 
“narrow” seat on the vessels, dehydration, and maybe reduced oxygen saturation 
are some of the factors that symptoms of venous thrombosis or pulmonary embo-
lism do not always appear immediately. They may occur up to 8 weeks after the 
travel [9, 10].
Regardless of whether it is a trip by car, train, bus, or plane, travel thrombosis 
(for flight travel also named “economy class syndrome”) will manifest up to 4 weeks 
after traveling according to the British Committee for Standards in Hematology up 
to 6 weeks after long-haul flights [9, 10]. It is estimated that 5–15% of all proven 
venous thromboembolism (VTE) occur in connection with long-haul flights [11, 12]. 
The risk is highest in the first week and then decreases continuously; the majority 
(approx. 60–75%) of all travel thrombosis are asymptomatic/low-symptom throm-
bosis exclusively located in the lower limbs, which is perceived as “unpleasant leg 
swelling/edema” due to long sitting with the legs hanging down [11, 12].
2. Epidemiology
The clinical relevance of these asymptomatic thromboses is questionable, but 
they may be the origin for the manifestation of deep vein thrombosis. So far, there 
is no prospective, controlled study with a sufficient number of cases (adequate 
statistical power) that proves an evidence-based association between air travel and 
the risk of venous thromboembolism (VTE). In order to demonstrate a significantly 
increased risk, a study including around 1 million passengers (+ controls) would be 
necessary [13].
The risk for VTE mainly depends on the flight duration, the number of 
flights within 3–4 weeks, and risk factors of each individual predisposing to 
VTE. According to meta-analyses from case-control studies, long-haul flights 
increase the risk of VTE by two to four times within the first 4 weeks. For every 
2 h of extended flight time, the VTE risk may increase by 26%. The risk of VTE is 
not increased in healthy passengers without risk factors and a flight duration of 
less than 3–4 h. It should be taken into account in this context that the basic risk 
for VTE in healthy women under 35 years without hormone intake is 1–2/10,000/
years and increases fourfold after the age of 40 [13–16]. Young women (<30 years) 
are up to three times more likely to experience VTE than young men. An observa-
tional study from France analyzed 116 pulmonary embolisms (PE) over a period 
of 13 years, which occurred immediately after landing. With approximately the 
same gender distribution of passengers, 78% of all PE affected women [13–16]. 
Overall, the incidence of PE was 0.61/1,000,000 female passengers (0.2/1,000,000 
male passengers). With a flight distance of more than 10,000 km, this risk rises 
to 7.2/1,000,000 female passengers. According to another study to 4.8/1,000,000 
female passengers with a flight duration over 12 h, the total rate of VTE in healthy 
women without oral contraceptives is estimated 1/5000 regardless of the flight 
duration [13–16].
3. Individual risk factors
At least 80% of all passengers (regardless of gender) have at least one identifi-
able risk factor for VTE (especially PE).
Air travel alone increases the risk of VTE by 1.8 (flight time 8–12 h) to 2.8 times 
(>12 h), factor V Leiden mutation by 13.6 times, and oral contraceptives even up 
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to 40 times; BMI > 30 kg/m2 do not significantly increase the risk for air travelers. 
Already in 2003, Martinelli et al. referred to the increase in VTE risk on long-haul 
flights (>8 h) in connection with congenital and acquired thrombophilia (risk 
increase by 16 times) and oral contraceptives (risk increase by 14 times). According 
to a recent calculation model by Kuipers et al. based on data from a previous cohort 
study including employees from international companies, the estimated absolute 
risk for symptomatic VTE in women after long-distance flights (>4 h) and oral 
contraceptive use was 1/259 flights and with hormone replacement therapy 1/405 
flights [2, 8, 17, 19].
The predisposing factors to VTE are mainly:
• Individual or family history of VTE.
• Presence of varicose veins.
• Pregnancy and the first month after giving birth.
• Oral estrogen-containing contraceptives: increased risk of VTE up to 20 times.
• Recent surgery.
• Cancer diseases.
Women with thrombophilia that had surgery or trauma within the last 3 months, 
taking oral contraceptives or being under hormone replacement therapy.
• Obesity.
• Height >1.90 or <1.60 m increased risk of VTE by 4–5 times [17–19].
• Obese patients with body mass index (BMI) greater than 30 kg/m2 and risk of 
VTE increased by 10 times.
3.1 Risk factors in association to flights
Travel participation can expose passengers to a variety of risk factors that 
may have impact on their health. Health professionals can obtain information 
from the International Maritime Health Association and Aerospace Medical 
Association website (www.imha.net and www.asma.org), respectively.
3.2 Factors that may affect passengers traveling by plane
3.2.1 Cabin pressure
At a normal altitude of 36,000–40,000 feet, the cabin pressure equals that of 
6000–8000 feet at sea level and is therefore at low levels resulting in a decrease 
in oxygen supply [20–22]. This is not dangerous for healthy people unless there 
are cardiopulmonary problems and hematological disorders, for example, sickle 
cell anemia. These problems are particularly pronounced when the airplane rises 
(because of the reduction in air pressure in the cabin, outflow from the middle 
ear and nasal cavities) and also during the cathode of the plane where there is 
an increase in air pressure in the cabin, inlet air, and the middle ear to balance 
the pressures. The reduced air humidity in the flight cabin of 10–20% (optimally 
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40–70%) in conjunction with other factors such as reduced drinking volume, 
excessive sweating, or increased diuresis due to increased alcohol/coffee consump-
tion can promote the development of dehydration, respiratory diseases, and finally 
of deep vein thrombosis.
3.2.2 Moisture content
It is low in cabin <20% and can cause skin dryness and eye and nose discomfort. 
Moisturizing lotion and sunscreen are recommended, whereas contact lenses are 
contraindicated.
3.2.3 Ozone
It is a form of oxygen with a different structure to its molecule located in the 
upper layers of the atmosphere and can irritate the upper respiratory system, but 
eyes and nose are decomposed by heat and eliminated by compressors.
3.2.4 Cosmic radiation
There are no special effects for passengers on board of the flight. The total 
effective dose from natural radiation exposure in Germany averages 2.1 millisievert 
(mSv)/year. The International Commission on Radiological Protection recom-
mends exposure of 1 mSv/year and 0.5 mSv/month as a guideline, within which 
there is no detectable risk of radiation damage. Internationally, radiation exposure 
during pregnancy of 1 mSv should not be exceeded totally, which is significantly 
lower than that associated with a potential health hazard (>20 mSv). The radiation 
exposure during air travel is clearly dependent on the route, altitude, and duration 
of the flight. The cosmic radiation in an altitude of 9–12 km is about 100 times 
higher than on the ground.
For short-haul flights (lower flight altitudes), a radiation exposure of on average 
0.001–0.003 mSv/h and for long-haul flights (higher altitude, other flight route) of 
0.005–0.008 mSv/h have been determined.
3.3 Motion sickness
It does not occur regularly except in case of atmospheric disturbances. If predis-
posed it is prudent to avoid alcohol and to supply appropriate medicines.
4. Recommendations
Nearly 50% of the passengers with DVT of one or more extremities may be 
asymptomatic. However, edema of the limb, pain, and signs as red and hot to touch 
skin are some of the symptoms. Unspecific symptoms of pulmonary embolism 
may be present, such as unexplained dyspnea, abnormal heart rhythm, chest pain, 
intolerance that may be aggravated by coughing or deep inhalation, coughing up 
blood, anxiety, dizziness, or a tendency to faint. Especially, people in high-risk 
groups should be informed about early recognition of these symptoms in order to 
seek for medical help. Preventive measures include sufficient hydration, avoidance 
of alcohol/excessive caffeine intake, and regular walking during the trip.
The risk of VTE is eightfold increased in patients with the factor V Leiden 
mutation that affects blood clotting. These passengers should be considered for 
heparin prophylaxis. According to the French Society of Cardiology, the probability 
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of venous thrombosis during an airline flight is multiplied by 2.81 in a healthy 
person, regardless of flight time. The risk is then increased by 26% for every 2 h of 
flight. Before traveling it is prudent to take the following recommendations into 
consideration:
Wear comfortable clothing, leave space under the front seat to allow mobility of 
the lower legs, change posture regularly, do exercises for feet regularly, and book 
aisle seat, if you are predisposed to VTE.
Walk regularly every 60–90 min, and drink a sufficient amount of fluids (at least 
150–200 ml every 2 h) which is especially important for people at increased risk of 
thrombosis. In these passengers well-fitted elastic compression stockings until the 
knee are recommended and in high-risk passengers additionally the subcutaneous 
administration of low molecular weight heparin 2–6 h before traveling.
4.1 Pregnancy and travel
It is estimated that there is 1 pregnant woman per 1000 air travelers. Reliable 
data on the incidence of VTE in pregnant women with long-haul flights are so far 
not available. Considering an approximately fivefold increased risk of VTE dur-
ing pregnancy (compared to nonpregnant women), various calculation models by 
Cannegieter and Rosendaal have shown an estimated incidence of venous thrombosis 
of 0.03–0.1% after one air travel in pregnancy. According to a cohort study including 
a small number of cases (26 thrombosis, 3 of them are pregnant women), the OR for 
DVT with air travel and pregnancy was 14.3 (95% CI, 1.7–121.0), corresponding to an 
estimated absolute risk of 1/109 flights [2, 23–25].
Overall, the absolute risk of VTE during pregnancy is 1–2/1000 pregnancies. 
This risk increases by fivefold in the puerperium. 20.4% of VTE manifest in the 
first, 20.9% in the second, and 58.7% in the third trimester; 95% of all postnatal 
VTE occur within 6 weeks postpartum. The risk of VTE in the puerperium is 20–80 
times higher than that in nonpregnant women. Due to the increased production 
of coagulation factors and a reduction in fibrinolytic activity, hypercoagulability 
occurs in physiological pregnancy. Healthy pregnant women compensate this hyper-
coagulable state by pregnancy-induced hemodilution and the increased perfusion 
in microcirculation. According to the risk classification for VTE by Andersen and 
Spencer, pregnancy and the puerperium were considered as moderate risk for VTE 
(OR between 2 and 9), even in connection with long-haul flights [2, 23–25].
According to RCOG Guideline No. 37a 2015, air travel of more than 4 hours is an 
independent risk factor for VTE (evidence level III). This risk increases with addi-
tional individual risk factors for VTE which have to be considered in the consulting 
practice (overview at risk factors for VTE associated with air travel). Regardless of 
pregnancy, the following “thrombogenic” factors were discussed in connection with 
long-haul flights.
4.2 Immobilization
Long-term immobilization with sitting for hours in a “cramped” posture (espe-
cially kinking of the legs and pressure of the edge of the seat on the popliteal veins) 
may promote venous stasis in the lower extremities. Air travelers over 190 cm and 
under 160 cm height are particularly at risk. In this context, it should be mentioned 
that sitting by the window is associated with a twofold higher risk of VTE than sit-
ting at the aisle. In passengers, with a BMI over 30, the risk of VTE is increased even 
by sixfold. Significant differences regarding the risk of thrombosis (measurement 
of the D-dimers) between the first/business class and the economy class have not 
yet been demonstrated; however, related data are limited [26–29].
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Other risk factors associated with air travel are dehydration, reduced air pressure 
and humidity in the aircraft cabin, disruption of circadian rhythm and hypobaric 
hypoxia and their effects on changes in the coagulation system [30, 31].
4.3 Recommendations for prevention
So far there are no evidence-based recommendations for the prevention of VTE 
during air travel, but there are some based on expert consensus (mostly grade D) 
in various international guidelines. Only the RCOG Scientific Impact Paper No. 1 
from 2013 and the ACOG Committee Opinion No. 443 of 2009 explicitly address 
air travel and pregnancy. A decisive prerequisite for adequate prevention (especially 
for pregnant women) is a careful individual assessment of risk factors by the doctor 
(gynecologist/family doctor) before starting the flight. This provides the basis for 
risk-adapted thromboembolism prophylaxis. A total of five guidelines make risk-
related recommendations including risk classification for VTE after air travel [26–29].
According to the AWMF guideline 003/001 (S3), long air flights or bus trips do 
not require any special prophylaxis measures apart from general basic measures; 
in individual cases when there are risk factors, calf-length compression stockings 
should be considered.
If the risk is low, general measures are enough. With intermediate risk, e.g., 
pregnancy/puerperium, in addition to the general measures from a flight duration 
of 4 h, the wearing of graduated compression stockings up to the knee is recom-
mended. The importance of compression stockings for thrombosis prophylaxis on 
long-haul flights (>4 h) also emerges from a 2006 Cochrane analysis (revised 2010) 
including 10 randomized trials [26–33].
The scientific studies (n = 2856) with moderate quality and different risk pro-
files for VTE were considered. The primary outcome criterion of this analysis was 
the rate of symptomatic and asymptomatic (diagnosed by sonography or phlebog-
raphy) deep vein thrombosis. Wearing well-fitted compression stockings has shown 
to reduce the rate of asymptomatic deep vein thrombosis from 3.6 to 0.2% (OR 
0.10; 95% CI 0.04–0.25; p < 0.00001); in addition, the frequency of leg edema was 
also significantly shown to be significantly decreased as reported by the LONFLIT-4 
study [26–35].
If there is a high risk of VTE, in addition to compression stockings, the prophy-
lactic subcutaneous administration of low-molecular heparin (LMH) after individual 
risk assessment should be considered; aspirin is not indicated in these cases [26–33].
5. General contraindications for air travel of pregnant women
Severe anemia <7.5 g/dl; otitis media and sinusitis; severe heart and lung diseases; 
recent gastrointestinal surgery, including laparoscopic surgery; bone fractures; risk 
of leg swelling, especially in the first few days after wearing one plaster cast; referred 
fear of flying are contraindications for air traveling [26–35].
5.1 Absolute and relative obstetric contraindications
It goes without saying that unclear symptoms such as bleeding, abdomen pain, 
gastrointestinal symptoms, or clinical signs of preeclampsia or thrombosis must 
be clarified before traveling, especially since most airlines issues demand a medical 
certificate about the safety air of travel. The 2nd trimester, especially the interval 
between the 18th and 24th week of gestation, is considered the safest time to travel 
because the risk of obstetric complications (e.g., premature labor) is lowest at this 
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time. In the third trimester, pregnancy risks, such as preeclampsia, intrauterine 
growth restriction, antenatal bleeding due to placenta previa, severe anemia, and 
the increased risk of premature birth (previous preterm birth, recurrent premature 
labor, and cervical insufficiency), should be excluded prior to the flight. Most 
airlines allow pregnant women with uncomplicated single pregnancy to travel 
up to (and including) 36th week of pregnancy and women with uncomplicated 
multiple-child pregnancy up to 32nd week of pregnancy, which is in accordance 
with the regulations of the International Air Travel Association. As shown in 
previous studies, there are still no uniform regulations for the transportation of 
pregnant passengers in civil aviation. It is therefore advisable to check the relevant 
conditions of carriage of the different airlines on their website before each flight; 
this also applies to the certification obligations. In addition, information about 
the destination/place of residence should be obtained before starting the flight, in 
particular about the climate, altitude, humidity, risk of infection, etc., and about 
the medical/obstetric (emergency) care on site [26–35].
5.1.1 Absolute contraindications
“Premature placental abruption” due to manifestation of contractions.
“Cervical insufficiency” premature labor, premature bladder jump.
“Suspected ectopic pregnancy”.
“Vaginal bleeding”.
“Impending abortion”.
“Preeclampsia” (previous/current pregnancy).
5.1.2 Relative contraindications
“Abnormal child growth”.
“Previous abortions/ectopic pregnancy”.
“Maternal age <15 or >35 years”.
“Multiple pregnancy”.
“Placenta previa, placental disorders” [26–35].
6. Discussion
6.1 General effects of travel in pregnant women’s health
The association between air travel and pregnancy outcome concerning early 
or late pregnancy loss, incidence of malformations placenta abruption, etc. is very 
limited. The average altitude for commercial long-haul flights is 10,000–12,500 m. 
The air pressure drops from 760 mmHg (at sea level) to 560 mmHg at flight level. 
This drop-in air pressure is largely compensated for by the cabin pressure in the 
aircraft (equivalence to an altitude of 1524–2438 m above sea level) so that an 
altitude of about 12,200 m is tolerated by the passengers without hypoxic stress. 
The partial pressure of oxygen in the arterial blood depends on the lung function 
(cave: chronic obstructive pulmonary diseases); in healthy passengers it drops 
from 95 mmHg to 53–78 mmHg in the airplane, and the arterial oxygen saturation 
decreases from 97 to 99% to 90–94% [36–41].
For healthy pregnant women who have sufficient oxygen saturation, this 
“relative” hypoxia in the plane poses no significant risk even for a healthy fetus. No 
influence on the fetal heart rate during short-haul flights was observed [30, 31, 42]. 
Due to the approximately 50% higher hemoglobin concentration compared to the 
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mother, the 20–30% higher oxygen affinity of fetal hemoglobin and the Bohr effect 
which guarantees a preferred oxygen release on the placental level, and negative 
effects on the fetuses are not to be feared. There is no need to fear mild hypoxia 
associated with air travel. However, this does not apply to pregnant women with 
reduced oxygen saturation due to underlying diseases (e.g., severe anemia, chronic 
obstructive pulmonary diseases) [41–48].
In general, a general attest must be introduced for the transportation of all 
pregnant passengers from the child’s extrauterine viability, i.e., from the 25th week of 
pregnancy. The certificate should be issued in the period from approximately 1 week 
to 2 days before departure in order to guarantee that it is up to date to some extent. 
In addition to the exact gestational age, risks must also be specified which should be 
related to the health risk for both the mother and the child, and a distinction between 
single and multiple pregnancies should be documented. Concerning multiple preg-
nancies, long-haul flights up to the 28th week of pregnancy or short-haul flights up 
to the 32nd week of pregnancy in these cases are recommended to prevent premature 
birth. Short-haul flights are those routes on which an airport can be reached within 
1 hour. Considering the average duration of pregnancy and birth in the case of single 
pregnancies, transport on long-haul flights up to the 36th week of pregnancy and on 
short-haul flights up to the 37th week of pregnancy is possible [41–48].
6.2 People’s health problems and thrombosis
For all traveling people, the risk of VTE is slightly increased. It is significantly 
increased in passengers who have particular risk factors such as advanced age, 
taking estrogen-containing oral contraceptives or are at hormonal replacement 
therapy, obesity, and the presence of factor V Leiden mutation, at most high or very 
low body height [49–52].
The underlying mechanism responsible for travel-related thrombosis is not 
fully understood. But the fact that risk has been found for all modes of travel 
suggests that immobility and associated venous stasis may be a key factor in 
generating the disease. The reduction of oxygen levels may be an additional 
reason for the initiation of thrombus formation during long air travel in groups 
of people with specific risk factors.
Additional abovementioned thrombogenic risk factors increase the risk of VTE 
significantly.
Low air pressure and reduced blood oxygenation increase the risk of deep vein 
thrombosis in susceptible air passengers.
To date, deep vein thrombosis in air passengers has been mainly associated with 
the fact that they have been stationary for long periods of time as is usually the case 
in air travel.
Deep vein thrombosis occurs in the lower limbs when there are long periods of 
inactivity or sedentary activity.
The risk is that the clot can move through the bloodstream to the heart, lungs, 
and brain. This can happen hours, days, or weeks later after the initial formation of 
thrombosis. It is the cause of a heart attack or stroke.
Studies have shown that the risk of deep vein thrombosis of the lower limbs 
increases by two to four times after an air trip [49–52].
They believe that the main culprit is the hypoxia of blood resulting from low cabin 
pressure and reduced oxygen levels of passengers compared to what is happening on 
the ground. The decrease in oxygen concentration in the blood seems to activate the 
coagulation system leading to the formation of clots.
In addition, this research provides us with important information about who is 
at greater risk than others.
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These include people carrying the Leiden-type factor V mutant of the blood 
coagulation system, women taking birth control pills, patients recently undergoing 
surgery, and some groups of cancer patients.
High-risk patients may be prescribed anticoagulant medicines such as aspirin, 
heparin, dipyridamole, clopidogrel (Plavix®), and others after medical evaluation 
and advice.
In addition, alcohol should be avoided in the flight, and passengers should be 
able to stretch their legs and do as much exercise and walking as possible. They can 
also wear special socks. These measures improve blood circulation and help prevent 
thrombosis and its consequences.
6.3 Air travel, pulmonary embolism, and thrombosis
Air travel can cause clots of the deep veins of the thigh and feet [49–52].
This thrombosis can in turn cause a pulmonary embolism which is a very serious 
condition which can cause death.
Thrombosis in the lower limbs (thighs, ankles, legs) is due to thickening phe-
nomena that occur in the deep long veins due to the many hours that passengers 
remain seated.
Lack of physical movement, dehydration observed in passengers, and alcohol 
consumption in flight are considered to be among the factors contributing to the 
occurrence of dangerous thrombotic conditions and pulmonary embolism.
In addition, some people may have inherited diseases with an increased risk of 
thrombosis and thus be at greater risk than air travel.
To date, 100 cases of pulmonary embolism due to venous thrombosis of the 
lower limbs have been described. A significant number of cases have died due to 
this condition. A case of lower limb amputation due to thrombosis has recently been 
described.
Research shows that clotting problems occur in the lower limbs and in up to 10% 
of long-haul passengers.
In fact, this syndrome is called by some people the “financial position” syndrome 
because passengers in these places do not have enough space in front of them to move 
their legs and remain motionless for many hours.
Researchers believe the incidence of pulmonary embolism after a long plane trip 
is higher.
The reason they are not detected is because the passengers are not immediately 
aware of what is happening or because the clinical signs are manifesting themselves 
severely a few hours after disembarkation. Even sudden deaths on flights or on 
landings may be due to a pulmonary embolism.
Some even argue that the problem is even greater and that the incidents detected 
constitute a very small percentage of those occurring.
6.4 Precaution that must be taken into account during traveling
Passengers should drink plenty of water to eliminate the risk of dehydration.
Avoid drinking alcohol and excessive caffeine intake.
Passengers should be able to get up, walk, do small exercises, or even stretch or 
move their lower limbs. It is also not good to cross legs.
Patients with a personal or family history of thrombosis should consult their 
physicians prior to an air trip [5, 52–54].
Some researchers recommend that passengers wear special high-pressure socks 
to improve blood circulation to the lower limbs. This is especially true for people at 
increased risk for thrombosis.
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For some passengers, taking low doses of aspirin before a long flight can be beneficial.
The World Health Organization recommends [5, 52–55] the following:
• Do not leave space under the front seat to allow for freedom of movement for 
the lower extremities.
• Exercises for feet.
• Often stop by car to walk, or get up regularly for a bit of unwinding and walking 
on an airplane, train, or boat.
• Do not drink too much water and avoid drinking alcohol.
• For persons at high risk of thrombosis, elastic compression with special socks 
and sometimes administration of low molecular weight heparin are recom-
mended (2–6 h before travel). The aspirin intake is controversial.
The mechanisms that have been implicated to date for this phenomenon are 
venous posture due to prolonged sitting posture, pressure exerted on the large vein 
behind the knee, blood buildup due to reduced intake and increased fluid loss, 
abnormalities in the system, and blood coagulation created in the subarctic and 
hypoxic environment.
Air travel or road trips, for many hours, run the risk of vein thrombosis in 
the legs and even more severe, pulmonary embolism. Posttraumatic thrombosis 
accounts for about 10% of all thromboses that occur.
According to the American College of Chest Physicians (ACCP) (2012) British 
Committee for Standards in Hematology (BCSH) (2011), British Thoracic Society 
(BTS) (2011) Traveler’s thrombosis: International Consensus Statement (Wien 
2008) [21, 57–59], low-risk, medium-risk, and high-risk factors for VTE after air 
travel are as follows:
Low risk
• No individual risk factors other than long-haul flights (ACCP, >6 h; BCSH, 
>6 h; BTS, >8 h/several flights in a short time (approx. 4 weeks)).
Medium risk
• Previous provoked VTE.
• Thrombophilia.
• BMI >30 kg/m2.
• Positive family history for VTE.
• Pronounced varicose.
• Combined oral contraceptives.
• Hormone replacement therapy.
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• Pregnancy.
• Puerperium: within 2 weeks (BTS) orup to 6 weeks (BCSH) postpartum.
• Height >190 cm/<160 cm (BTS).
High risk
• Previous idiopathic VTE.
• Cancer.
• Major surgery/trauma within.
• The last 4–6 weeks.
• Severe underlying diseases.
• Immobilization (e.g., plaster cast).
• Homozygous or combined congenital thrombophilia.
• ≥2 risk factors under B.
Recommendations for the prevention of deep leg vein thrombosis on long-haul 
flights are as follows:
Low risk
General measures:
• Physical activity: regular walking around in the corridor every 2–3 h.
• Movement of the legs (calf muscles, e.g., “foot rocker”) at the seat.
• All 30 min, isometric exercises.
• Sitting in the aisle (freedom of movement):
• Feet should reach the floor.
• Cave: bending the popliteal veins.
• Avoid dehydration:
• Regular liquid intake (at least 250 ml every 2 h).
• No excessive alcohol/coffee enjoyment.
• Do not take tranquilizers/sleeping pills:
• Cave: prolonged sleep in a cramped posture.
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Medium risk
Pregnancy, puerperium.
• Customized, graduated compression stockings to the knee (15–30 mmHg 
compression in ankle).
High risk
Previous VTE, symptomatic thrombophilia.
Additional (grade 2C/2D):
• Low molecular weight heparin (e.g., 5000 IU dalteparin s.c.) 6–12 h before the 
flight and 1–3 days after the flight (individual decision).
• No aspirin.
6.5 What causes vein thrombosis and pulmonary embolism?
Clots can be formed at various points, in the legs and in the thighs, with similar 
problems. All veins have valves every 10–12 cm, and some of them can form clots.
If the clot stays there, then the member has swelling and pain. Small fever may 
occur, and the member may be warmer. The most serious complication, however, is 
pulmonary embolism (PE), which occurs in 25% of cases with thrombosis. If the clot 
is detached, it is transported through the veins and eventually clamped to the lung. The 
condition can appear immediately or even 2 weeks after the long journey. The most 
common symptoms to suspect pulmonary embolism are sudden chest pain, dyspnea, 
dizziness, fever, hemoptysis, etc. Symptoms depend on the size of the plunger and the 
size of the vessel, the age of the person, if he or she is suffering from other diseases, etc. 
Immediate admission to the hospital is required for diagnosis and special treatment. In 
rare cases, a part of the clot can cause embolism in other organs, such as the brain.
People predisposed to thrombosis, as well as patients with previously mentioned 
illnesses, should be consulted by their physician prior to long journeys. In these 
individuals, it is recommended to inject antithrombotic (heparin) once 24 h before 
flight. It is also recommended to take aspirin before takeoff, except for pregnant 
women who are not allowed [5, 53–56].
6.6 Practical and useful tips
• Wear comfortable clothing.
• Leave space under the front seat to allow freedom of movement for the lower 
legs.
• Change your posture regularly and do exercises for your feet.
• Take regular breaks to walk.
• Drink plenty of liquids.
• For persons at high risk of thrombosis, elastic compression with special socks is 
recommended and sometimes administration of low molecular weight heparin 
(2–6 h before travel).
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People suffering from diseases that increase the risk of venous thromboembolism 
should follow the guidelines above, and the possibility of administering low molecu-
lar weight heparin (2–4 h before or earlier before flying) may also be considered.
In patients receiving anticoagulants, the dose should be reassessed.
Overall, however, there is insufficient data on pregnancy complications after 
air travel.
Occasional air travel, especially in the second trimester, is safe for healthy 
pregnant women and their child, according to the current state of knowledge, and 
has no negative effects on the course of pregnancy. Before starting the flight, the 
gynecologist should carefully ascertain the patient’s own (pre-existing illnesses) 
and obstetric history, as well as individually check the previous course of pregnancy 
(pregnancy-related risks) to identify pregnant women with risk factors who are 
advised against traveling by air. In any case, it is advisable to consider the different 
conditions of carriage of the airlines (including mandatory certification) and to 
obtain information about the destination of the flight. A drop-in air pressure, a 
reduction in partial oxygen pressure, and air humidity are generally not a problem 
for healthy pregnant women and their children. Dehydration during long-haul 
flights should be avoided. A radiation dose of 1 mSV should not be exceeded during 
pregnancy; pregnant women with frequent long-haul flights near the pole (e.g., 
Europe-North America) should take care of this. Most people believe that commer-
cial air travel does not increase the risk of pregnancy complications (e.g., premature 
birth) in healthy pregnant women [5, 53–57, 60].
The estimated radiation dose for infants/toddlers should be 0.05 μSV/scan, 
which for the fetuses are negligible [61].
7. Conclusion
Travel thrombosis in connection with long-haul flights (>4 h flight time) are 
rare (about 1/4500 passengers) and mostly affect the deep veins of the calf muscles. 
The proportion of pulmonary embolisms is significantly higher for female pas-
sengers than for male passengers (flight duration > 12 h: 4.8–7.2/1 million). The 
risk of venous thromboembolism depends primarily on the duration of the flight, 
the number of flights within 4 weeks, and individual thrombogenic risk factors. 
As a result of hypercoagulability and venous stasis, the risk for pregnant women is 
increased, and it is estimated at 0.03–0.1%. Long-term immobilization is the most 
important predisposing factor; the importance of hypobaric hypoxia and dehydra-
tion is controversial.
Before starting the flight, especially pregnant women are advised to carefully 
assess their risks. To reduce risk, in addition to general measures (e.g., physical 
activity), wearing graded, well-fitting compression stockings is recommended and 
if there is a high individual risk (e.g., previous VTE), prophylaxis administration of 
low molecular weight heparin before and immediately after the flight.
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